OVID Competitors & Alternatives
Compare Ovid Therapeutics Inc with similar stocks in the same industry
Biotechnology
OVID
Main Stock$2.69
Tradestie Score
55
Market Cap
$97.42M
Revenue Growth
8.4%
Analyst Upside
+103.4%
Top Competitors
233 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$15.23
|
$540.97M | - | 55 | Compare |
|
PRTA
Prothena Corporation plc Ordinary Shares
|
$9.69
|
$533.99M | - | 55 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$13.98
|
$529.35M | 6.9 | 62 | Compare |
|
OCGN
Ocugen, Inc. Common Stock
|
$1.51
|
$524.67M | - | 57 | Compare |
|
MNPR
Monopar Therapeutics Inc. Common Stock
|
$97.79
|
$522.78M | - | 56 | Compare |
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$2.32
|
$512.39M | - | 59 | Compare |
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$38.72
|
$505.12M | 2.0 | 54 | Compare |
|
RGNX
REGENXBIO Inc.
|
$13.28
|
$493.52M | - | 56 | Compare |
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$97.58
|
$492.21M | - | 52 | Compare |
|
XOMA
XOMA Royalty Corporation Common Stock
|
$43.00
|
$474.20M | 27.1 | 59 | Compare |
More OVID Analysis
Data updated: Jul 04, 2026 | Industry: Biotechnology (SIC 2834)
233 stocks in this industry